RSS Facebook Twitter YouTube

Hematology Nursing

Inpatient palliative care improves QOL for HSCT patients

Erilyn Riley Read Article
Published: 02/27/17

Doctor and hospitalized patient
Photo courtesy of CDC

New research shows that patients who received inpatient palliative care while undergoing hematopoietic stem cell transplant (HSCT) experienced significant improvements in quality of life (QOL), decreases in depression, and reductions in symptom burden compared to patients who received transplant care alone. Areej R. El-Jawahri, MD, of Harvard Medical School in Boston, Massachusetts, presented these results at the 2017 BMT Tandem Meetings. [Read Article]

Walking can benefit advanced cancer patients

HT Staff Read Article
Published: 02/19/17

Group walk in Epsom, England
Photo courtesy of Walking
for Health/Paul Glendell

Walking for 30 minutes 3 times a week can improve quality of life for patients with advanced cancer, according to research published in BMJ Open. The study indicated that some patients with advanced cancer may not be able to commit to weekly walks with a group of fellow patients. However, some patients enjoyed walking in groups, and most reported benefits from regular walks, whether taken alone or with others. [Read Article]

Cancer survivors report pros and cons of telehealth

HT Staff Read Article
Published: 02/15/17

Doctor using a smartphone
Photo by Daniel Sone

Cancer survivors report a range of benefits and detriments related to telehealth, according to research published in the Journal of Medical Internet Research. Telehealth is the use of technology to provide remote, personalized healthcare to patients. Telehealth services allow patients to have meetings and follow-up consultations with healthcare professionals either on the phone or through online services at a time that suits the patients. [Read Article]

Childhood cancer treatment linked to psychosexual development

HT Staff Read Article
Published: 02/06/17

Child with cancer
Photo by Bill Branson

Researchers say the intensity of neurotoxic treatment given to children with cancer may be an indicator of their risk for psychosexual impairment in adult life. The researchers compared adults who survived childhood cancer to matched control subjects and found that, overall, the 2 groups reported similar sexual and romantic experiences. However, cancer survivors who received high-dose neurotoxic treatment had inferior psychosexual development. [Read Article]

Kids, parents over-report ALL treatment adherence

HT Staff Read Article
Published: 02/03/17

Prescription pills

New research published in Blood suggests young patients with acute lymphoblastic leukemia (ALL)—and their parents—are likely to over-report treatment adherence. In a study of 416 pediatric ALL patients, 84% of patients or their parents said the patients took more 6-mercaptopurine (6MP) than they actually did. 6MP is prescribed for 2 years after chemotherapy with the goal of producing durable remissions, but studies show that over 95% of the . . . [Read Article]



{icon} {author} Read Article
Published: {pubDate}